-
News | 2022.02.16
COVID-19: reducing outbreak risk with repeated antigen screening in healthcare facilities
With the emergence of the Omicron variant, healthcare facilities remain highly vulnerable to virus spread. Effective surveillance of viral presence in these facilities is therefore crucial and needs to be adapted according to outbreak risk. Scientists from the Institut Pasteur worked with colleagues to analyze the reactive use of antigen testing in a long-term care facility following a detected...
-
Article | 2024.04.30
Paul-Louis Simond, world traveler working on multiple diseases
A French naval medical officer, Paul-Louis Simond traveled the world and studied many diseases. After heading up a leprosarium in French Guiana from the age of 24, he spent several years in Indochina where he battled smallpox, and then in China.
-
Document de presse | 2024.05.28
AFROSCREEN: a key network for genomic surveillance in Sub-Saharan Africa
Three years after its launch, AFROSCREEN meets all its objectives, developing effective genomic surveillance to tackle epidemics in sub-Saharan Africa The AFROSCREEN project, financed to the tune of €10 million by Agence Française de Développement (AFD), has been working since 2021 to set up or strengthen sequencing platforms and build an operational network for monitoring emerging...
-
News | 2024.11.04
A novel method for producing DNA-based therapies
Scientists have combined enzyme and chemical techniques to develop an innovative method for producing synthetic DNA molecules. This novel approach opens up many new possibilities, especially for the production of large molecules that can be used for future therapies.
-
Fiche maladie | 2015.10.06
Aspergillosis
Aspergillosis is a general term for infections caused by a type of mold (fungus) belonging to the genus Aspergillus. The mold that causes aspergillosis can be found everywhere in the environment in the form of spores, but in certain conditions it can become pathogenic, for example in immunocompromised people or those with chronic lung disease. The diseases caused by Aspergillus differ depending...
-
Document de presse | 2025.02.28
Bpifrance and the Institut Pasteur strengthen cooperation to support launch of startups based on research
On February 27, 2025, Yasmine Belkaid, President of the Institut Pasteur, and Nicolas Dufourcq, CEO of Bpifrance, signed a cooperation agreement aimed at using their resources and skills to improve the transfer to industry of research results. This strategic partnership is designed to encourage the emergence of startups and innovative projects based on the Institut Pasteur’s research. It follows...
-
News | 2023.05.23
Creation of an European Biocluster for Emerging Infectious Diseases
The project "Infectious Diseases Cluster" (IDCluster) has been selected for the Healthcare Innovation 2030 plan. This strategy aims to strengthen biomedical research in France. Coordinated by Lyonbiopôle and supported by the Auvergne-Rhône-Alpes region, this European-scale cluster aims to accelerate progress in the field of emerging diseases, by working with the Institut Pasteur among others.
-
Article | 2019.05.21
Antimicrobial resistance
Antimicrobial resistance is dramatically increasing worldwide and is becoming one of the most urgent public health threats. There is an urgent need for actions to reverse the curve of antimicrobial resistance dissemination and to develop innovative drugs (antibiotics, antiparasitic, antifungals, antivirals, antivectors) and therapeutic strategies for safer and sustainable treatments of infectious...
-
News | 2025.06.30
Tuberkiller: a rap to explain tuberculosis research
As part of the video series "My PhD at the Institut Pasteur," which highlights the work of the institute’s PhD students through short and accessible formats, a new episode features Yaëlle Wormser, a doctoral student in microbiology. Through a powerful rap, she raises public awareness about her research on tuberculosis, an infectious disease responsible for over 10 million cases and 1.25 million...
-
Document de presse | 2014.11.11
Sanofi - Institut Pasteur Awards 2014
Paris, France - November 13, 2014 - Sanofi and the Institut Pasteur awarded the Sanofi - Institut Pasteur awards for the third consecutive year. Four internationally renowned researchers were honored today for their work carried out in two major fields concerning world health: neglected tropical diseases and immunology.Press releaseNovember 13th, 2014 Created in 2012, these awards encourage...